华北制药(600812.SH)：全资子公司通过药品GMP符合性检查

Core Viewpoint - North China Pharmaceutical Group's subsidiary, North China Pharmaceutical Group Shentai Pharmaceutical Co., Ltd., has received a GMP compliance inspection notice from the Hebei Provincial Drug Administration for its product, Piperacillin Sodium, which is used to treat infections caused by Pseudomonas aeruginosa and other sensitive Gram-negative bacteria [1]. Group 1 - The product name is Piperacillin Sodium, which is primarily indicated for pneumonia, sepsis, respiratory, biliary, and urinary tract infections, as well as subacute endocarditis and purulent meningitis [1].